AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety.

J Behav Ther Exp Psychiatry. 1996 Mar;27(1):51-6. Unique Identifier : AIDSLINE MED/96409539
Kraus RP; Nicholson IR; Department of Psychiatry, University of Western Ontario, London,; Canada.

Abstract: Abel's (1993) review of treatments for obsessive compulsive disorder (OCD) indicated that both behavioral treatment (exposure with response prevention, and biological treatment (specific serotonin reuptake inhibiting drugs) are effective. It was recognized that having both available for patients is preferable because there would be situations where one treatment is more appropriate than the other. One indication for using drugs would be where situational constraints do not allow for effective exposure treatment. We present a case study of a microbiology technician with AIDS-related OCD who had an excellent response to the administration of fluoxetine without relapse when the drug was discontinued.
Keywords: Acquired Immunodeficiency Syndrome/*PSYCHOLOGY Adult Case Report Combined Modality Therapy Desensitization, Psychologic/*METHODS Fear Female Fluoxetine/*ADMINISTRATION & DOSAGE Human Laboratory Personnel/*PSYCHOLOGY Microbiological Techniques Obsessive-Compulsive Disorder/PSYCHOLOGY/*THERAPY Occupational Diseases/PSYCHOLOGY/*THERAPY Personality Inventory Serotonin Uptake Inhibitors/*ADMINISTRATION & DOSAGE Treatment Outcome JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDpsychologyadultcasereportcombinedmodalitytherapydesensitization,psychologic/KWDmethodsfearfemalefluoxetine/KWDadministration&dosagehumanlaboratorypersonnel/KWDpsychologymicrobiologicaltechniquesobsessive-compulsivedisorder/psychology/KWDtherapyoccupationaldiseases/psychology/KWDtherapypersonalityinventoryserotoninuptakeinhibitors/KWDadministration&dosagetreatmentoutcomejournalarticle
970228
M9721870

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .